Skip to main content
. 2020 Jan 21;46(3):200–209. doi: 10.1136/bmjsrh-2019-200474

Table 1.

Usual use of contraceptive methods among women aged 16–44 years who ever reported vaginal intercourse: Natsal-2 and Natsal-3

Denominator (unweighted, weighted)* Natsal-2: usual use Natsal-3: usual use
5178, 4651 5237, 3657
n % (95% CI) n % (95% CI)
Most effective methods 1141, 1077 21.5 (20.4 to 22.8) 944, 762 21.1 (19.7 to 22.6)
 Intrauterine device 265. 221 4.4 (3.9 to 5.0) 230. 187 5.2 (4.4 to 6.1)
 Hormonal intrauterine system (Mirena) 44, 35 0.7 (0.5 to 1.0) 105, 96 2.6 (2.1 to 3.3)
 Implant 15, 14 0.3 (0.2 to 0.5) 348, 194 5.4 (4.8 to 6.0)
 Male sterilisation 445, 446 8.9 (8.1 to 9.8) 162, 177 4.9 (4.1 to 5.8)
 Female sterilisation 382, 370 7.4 (6.6 to 8.3) 106, 114 3.2 (2.6 to 3.9)
Effective methods† 1940, 1747 34.9 (33.5 to 36.4) 1953, 1194 33.1 (31.6 to 34.6)
 Pill 1769, 1599 32.0 (30.6 to 33.4) 1741, 1064 29.5 (28.1 to 30.9)
 Injections 171, 148 3.0 (2.5 to 3.5) 210, 128 3.6 (3.0 to 4.1)
Less effective methods† 1641, 1417 28.3 (27.0 to 29.7) 1356, 940 26.1 (24.6 to 27.5)
 Male condom 1360, 1184 23.7 (22.4 to 25.0) 1229, 833 23.1 (21.7 to 24.5)
 Cap/diaphragm† 45, 31 0.6 (0.4 to 0.9)
 Natural family planning (rhythm) 104, 85 1.7 (1.3 to 2.1) 37, 35 1.0 (0.7 to 1.4)
 Withdrawal 173, 150 3.0 (2.6 to 3.5) 92, 75 2.1 (1.6 to 2.6)
No method used 1030, 826 16.5 (15.5 to 17.6) 1173, 853 23.6 (22.3 to 25.0)
 No vaginal sex in last year 463, 309 6.0 (5.4 to 6.7) 408, 271 7.4 (6.6 to 8.3)

*Denominator is Natsal population aged 16–44 years, excluding those who have never had vaginal intercourse.

†Numbers too small for patch (effective), cap/diaphragm in Natsal-3 (less effective), female condom (less effective), spermicides (less effective)